BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BEACONPHAR

All Eps Dividend Board Agm Q1 Q2 Q3

BEACONPHAR 21-Nov-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 28, 2021 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

BEACONPHAR 12-Aug-2021

Refer to their earlier news disseminated by DSE on 28.03.2021 regarding response to DSE's Query, the company has further informed that the Syrian Arab Republic has issued GMP (Good Manufacturing Practice) Certificate to the Company for the purpose of register the Beacon Pharmaceutical Ltd. for medicine.

BEACONPHAR 28-Jul-2021

In response to a DSE query dated July 27, 2021, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.

BEACONPHAR 19-May-2021

(Q3 Un-audited): The Company has further informed that the turnover of the Company for the period July 2020 to March 2021 has been increased by 50% from the corresponding period of previous year. On the other hand, total Operating Expenses has been increased by only 9.60% from the corresponding period of previous year. Due to drastic increase of turnover and decrease of Operating expenses for the nine month period from July 2020 to March 2021 the EPS has been increased.

BEACONPHAR 19-May-2021

(Q3 Un-audited): EPS was Tk. 2.01 for January-March 2021 as against Tk. 0.25 for January-March 2020; EPS was Tk. 3.27 for July 2020-March 2021 as against Tk. 0.55 for July 2019-March 2020. NOCFPS was Tk. (1.05) for July 2020 -March 2021 as against Tk. (1.18) for July 2019 -March 2020. NAV per share was Tk. 22.71 as on March 31, 2021 and Tk. 18.75 as on March 31, 2020.

BEACONPHAR 05-May-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 18, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.

BEACONPHAR 28-Mar-2021

(Continuation news of BEACONPHAR): But no written agreement/deal has made yet. On the other hand worldwide COVID-19 situation is going down very roughly. In this situation we are not confirm regarding this deal before signing the agreement. We also assure you, after completion of the signing ceremony with the government of Syria we will inform you and other regulatory authorities on time." (end)

BEACONPHAR 28-Mar-2021

(Continuation news of BEACONPHAR): If the Syrian government agreed we may export USD 5.00 million worth of pharmaceuticals to Syria by December, 2021 and have the potential to increase exports to USD 10.00 million within one year which may have a positive financial impact of the Company. (Cont. 2)

BEACONPHAR 28-Mar-2021

In response to a DSE query dated March 24, 2021 regarding clarification on recent news published in the newspaper, the Company has informed that "We like to inform that a technical team of the government of Syria inspected the plant of Beacon Pharmaceuticals Limited on March 08, 2021. They expressed their satisfaction verbally on the Company?s overall operations in drugs manufacturing. (Cont. 1)

BEACONPHAR 16-Mar-2021

In response to a DSE query dated March 15, 2021, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.

Previous Next page